Followers | 170 |
Posts | 8965 |
Boards Moderated | 0 |
Alias Born | 01/24/2011 |
Thursday, February 11, 2016 1:50:47 PM
There is no reason to predict a stock price for HEMP because there are too many unknowables, such as when we might see a paid pump like the one a couple of weeks ago (Trader's Choice), a PR from Perlowin that implies much more is going on than actually is, or share selling to raise cash that also increases the number of outstanding shares.
That's why I generally discuss over/undervaluation for HEMP with regards to the market cap relative to the reported & possible number of outstanding shares.
I wrote the following on Oct 1, 2015, 3Q/15 had ended and the OS was thought to be 320M shares (based on the 2Q/15 filing).
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=117410282
On Oct 1, 2015, HEMP was selling for about $0.05. When the 3Q/15 report was filed, we found that HEMP again had a big loss and that the OS had increased to 398M shares, up 24%. Since then, HEMP's stock price has fallen about 22%, and the market cap based on the 398M OS is around $15.5M, so maybe it's a little undervalued compared to the $17M cap of Oct 1, 2015.
OTOH, I'm quite sure that the OS has continued to increase, and HEMP will be showing another unprofitable quarter in 4Q/15.
The 1Q/16 results will be pumped by today's announced deal with FUTL (which I call FUTiLe,) but I think that the street will see through that.
HEMP won't justify a higher market cap until it begins to process Kenaf and shows that it can profitably sell the finished products.
"Soylent Green is people!!!"
Detective Robert Thorn: Telling uncomfortable truths since 2022
DRT is Charleton Heston's character in the 1973 movie, Soylent Green, set in the year 2022, and is not my real name
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM